Presentation ESC 2022 Treatment In the Morning or Evening: The TIME Study Results Presenter: Thomas MacDonald August 29, 2022 REGISTER for free or LOG IN to view this content Presentation ESC 2022 Up Next Presentation ESC 2022 DANFLU-1 – High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults Presenter: Niklas Dyrby Johansen August 29, 2022 More slides + Presentation ESC 2022 Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR) Presenter: Wilfried Mullens August 29, 2022 Presentation TCT 2022 Payer's Perspective Presenter: Lonny Reisman September 16, 2022 We Recommend
Presentation ESC 2022 DANFLU-1 – High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults Presenter: Niklas Dyrby Johansen August 29, 2022
Presentation ESC 2022 Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR) Presenter: Wilfried Mullens August 29, 2022